Non-muscle-invasive Bladder Cancer Clinical Trial
Official title:
External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the CUETO Group
Independent validation of Uromonitor as a non-invasive biomarker of recurrence of Non Muscle Invasive Bladder Cancer
This study is intended as an independent validation series for previous studies performed in several European centers with less statistical power. We expect to validate the results from a previous study, reaching the sensitivity and specificity data obtained at generation and first external validation papers. The overall goal of this study is to perform a bigger external multicenter validation study to evaluate the sensitivity, specificity, NPV and PPV of Uromonitor for the detection of bladder cancer recurrence in an independent series of patients. The specific objectives of this study protocol are the following: Main endpoint: • To evaluate the clinical sensitivity, specificity, NPV and PPV of Uromonitor in the detection of bladder cancer recurrence in patients previously diagnosed (over the last 3 months to 2 years) of NMIBC, treated or not, by testing a total of 600 patients (EVALUATION-CUETO Study) ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05483868 -
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
|
Phase 1 | |
| Not yet recruiting |
NCT05547516 -
Blue Laser -5ala Photodynamic Therapy (PDT) in High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients
|
N/A | |
| Not yet recruiting |
NCT05580354 -
Safety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder Cancer
|
Phase 4 | |
| Recruiting |
NCT05519241 -
A Phase I Intravesical PPM Therapy for NMIBC
|
Phase 1 | |
| Not yet recruiting |
NCT05002556 -
AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer
|
||
| Recruiting |
NCT05544552 -
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05796375 -
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
|
N/A | |
| Active, not recruiting |
NCT03528694 -
Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer
|
Phase 3 | |
| Recruiting |
NCT05790850 -
Pre-Habilitation With Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)
|
N/A | |
| Completed |
NCT03664258 -
A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X)
|
||
| Not yet recruiting |
NCT05962541 -
Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)
|
Phase 4 | |
| Not yet recruiting |
NCT03950362 -
Bladder PREserVation by RadioTherapy and Immunotherapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer
|
Phase 2 | |
| Recruiting |
NCT05710848 -
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05232136 -
OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05825950 -
Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
|
||
| Recruiting |
NCT05626101 -
Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study
|
N/A | |
| Recruiting |
NCT05538663 -
Intravesical BCG vs GEMDOCE in NMIBC
|
Phase 3 | |
| Recruiting |
NCT06245759 -
The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients
|
||
| Active, not recruiting |
NCT04690699 -
LUMINOS-103: A Basket Trial Evaluating the Safety and Efficacy of Lerapolturev (PVSRIPO) and Lerapolturev in Combination With Anti-PD-1/L1 Checkpoint Inhibitors in Patients With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT05675176 -
Antegrade Observational Comparative Study for the Intravesical Instillation Therapy of Bacillus Calmette Guerin With the Use of Different Types of Urinary Catheters in Patients With Urinary Bladder Cancer
|